Enorama Pharma AB (publ) (STO:ERMA)
Sweden · Delayed Price · Currency is SEK 1.240
+0.848 (216.33%)
Aug 14, 2026, 5:29 PM CET
Enorama Pharma AB Revenue
Enorama Pharma AB had revenue of 1.90M SEK in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to -1.01M. In the year 2025, Enorama Pharma AB had annual revenue of -6.74M.
Revenue (ttm)
-1.01M
Revenue Growth
-86.55%
P/S Ratio
42.39
Revenue / Employee
545.50K
Employees
4
Market Cap
92.49M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | -6.74M | -34.35M | - |
| Dec 31, 2024 | 27.61M | 26.49M | 2,363.16% |
| Dec 31, 2023 | 1.12M | -8.32M | -88.13% |
| Dec 31, 2022 | 9.44M | -3.50M | -27.06% |
| Dec 31, 2021 | 12.95M | 7.83M | 152.77% |
| Dec 31, 2020 | 5.12M | -5.41M | -51.38% |
| Dec 31, 2019 | 10.54M | -1.55M | -12.83% |
| Dec 31, 2018 | 12.09M | 10.09M | 506.07% |
| Dec 31, 2015 | 1.99M | 611.00K | 44.18% |
| Dec 31, 2014 | 1.38M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| EQL Pharma AB | 432.35M |
| Cinclus Pharma Holding AB | 67.51M |
| Nanexa AB | 54.41M |
| Enzymatica AB | 51.93M |
| Newbury Pharmaceuticals AB | 35.02M |
| Moberg Pharma AB | 16.76M |
| Orexo AB | 16.60M |
| Dicot Pharma AB | 200.00K |
Enorama Pharma AB News
- 3 months ago - Enorama Pharma AB Quarterly report: Q1 2026 - Filings
- 5 months ago - Enorama Pharma AB Quarterly report: Q4 2025 - Filings
- 5 months ago - Enorama Pharma AB Annual report: Q4 2025 - Filings
- 9 months ago - Enorama Pharma AB Quarterly report: Q3 2025 - Filings
- 1 year ago - Enorama Pharma AB Quarterly report: Q2 2025 - Filings